Search results with tag "Systemic anti"
NHS England » Management extravasation of a systemic anti ...
www.england.nhs.ukMgt of Extravasation of a Systemic Anti-Cancer Therapy including Cytotoxic Agents v1.docx Document Purpose The purpose of this guideline is to provide clear guidance on the causes, prevention, recognition and management of an extravasation of a Systemic Anti-Cancer Therapy used in the treatment of malignant disease in the patient
NHS England » Systemic anti-cancer treatment management ...
www.england.nhs.ukSystemic Anti-Cancer Therapies (SACT). This guideline has been developed to support the handling, prescribing and administration of SACT agents for adult patients within the West Midlands Network. Note: Please refer to separate individual trust policy for guidance on intrathecal drug administration. 2. INTRODUCTION
Extravasation Classification of Systemic Anti-Cancer ...
www.hse.ieBackground Drugs used in Systemic Anti Cancer Therapy (SACT) particularly cytotoxics, can be extremely irritating and cause damage if they extravasate or infiltrate into surrounding tissues during intravenous administration.
Systemic Anti-Cancer Therapy (SACT) Competency Passport
www.ukons.orgSystemic Anticancer Therapy refers to all drugs, irrespective of their route of administration, with direct anti-tumour activity, including traditional cytotoxic chemotherapy such as cyclophosphamide, hydroxycarbamide, small molecule/antibody treatments such as imatinib, rituximab, immunotherapies such as nivolumab, ipilimumab
Systemic Anti- Cancer Therapy (SACT) Safe Handling and ...
www.londoncanceralliance.nhs.ukPage 2 of 8 Outcome Theoretical Application: Safe Unsafe What does this competency Cover? This competency assessment is concerned with the skills and knowledge required to safely deliver SACT only (excluding Intrathecal route).